Cargando…

Analysis of Adverse Drug Reactions with Carbamazepine and Oxcarbazepine at a Tertiary Care Hospital

PURPOSE: To describe adverse drug reactions (ADRs) to carbamazepine (CBZ) and oxcarbazepine (OXC), including severe cutaneous ADRs, at a tertiary care hospital over a 10-year period. MATERIALS AND METHODS: The frequency and clinical features of ADRs caused by CBZ and OXC were analyzed using the phar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jung Eun, Min, Kang Ryul, Kim, Soo Hyun, Kim, Alec Hyungtack, Kim, Seong Taek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515781/ https://www.ncbi.nlm.nih.gov/pubmed/32975062 http://dx.doi.org/10.3349/ymj.2020.61.10.875

Ejemplares similares

Cutaneous adverse drug reactions induced by Oxcarbazepine
por: Hsiao, Yi-Hsin, et al.
Publicado: (2014)

Implementation of HLA-B*15:02 Genotyping as Standard-of-Care for Reducing Carbamazepine/Oxcarbazepine Induced Cutaneous Adverse Drug Reactions in Thailand
por: Tiwattanon, Kanyawan, et al.
Publicado: (2022)

Symptomatology of carbamazepine‐ and oxcarbazepine‐induced hyponatremia in people with epilepsy
por: Berghuis, Bianca, et al.
Publicado: (2021)

Why should we monitor for hematologic adverse drug reactions to oxcarbazepine?
por: Jang, Gwang Cheon
Publicado: (2019)

EHMTI-0355. Comparison of carbamazepine and oxcarbazepine tolerability in patients with trigeminal neuralgia
por: Cregg, R, et al.
Publicado: (2014)

Comparison of tolerability and adverse symptoms in oxcarbazepine and carbamazepine in the treatment of trigeminal neuralgia and neuralgiform headaches using the Liverpool Adverse Events Profile (AEP)
por: Besi, E., et al.
Publicado: (2015)

Oxcarbazepine-induced tardive dyskinesia: A rare adverse reaction
por: Hergüner, M. Özlem, et al.
Publicado: (2010)

Randomized trial of betahistine mesilate tablets as augmentation for oxcarbazepine and carbamazepine in treating vestibular paroxysmia
por: Xue, Hui, et al.
Publicado: (2018)

Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain
por: Di Stefano, Giulia, et al.
Publicado: (2014)

A genome‐wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepine
por: Berghuis, Bianca, et al.
Publicado: (2019)

The pharmacogenomics of carbamazepine-induced cutaneous adverse drug reaction in the South of Vietnam
por: Nguyen, Ai-Hoc, et al.
Publicado: (2023)

Antibiotic-Related Adverse Drug Reactions at a Tertiary Care Hospital in South Korea
por: Jung, In Young, et al.
Publicado: (2017)

Effects of oxcarbazepine versus carbamazepine on tinnitus: A randomized double-blind placebo-controlled clinical trial
por: Gerami, Hooshang, et al.
Publicado: (2012)

Oxcarbazepine-induced systemic lupus erythematosus: A rare and serious adverse drug reaction to a common anticonvulsant
por: Sinha, Anwita, et al.
Publicado: (2021)

Evaluation of Factors Impacting the Efficacy of Single or Combination Therapies of Valproic Acid, Carbamazepine, and Oxcarbazepine: A Longitudinal Observation Study
por: Peng, Qilin, et al.
Publicado: (2021)

HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in Vietnamese
por: Nguyen, Dinh Van, et al.
Publicado: (2015)

Carbamazepine-Mediated Adverse Drug Reactions: CBZ-10,11-epoxide but Not Carbamazepine Induces the Alteration of Peptides Presented by HLA-B∗15:02
por: Simper, Gwendolin S., et al.
Publicado: (2018)

Oxcarbazepine and Hyponatremia
por: Čiauškaitė, Julija, et al.
Publicado: (2022)

Effect of Oxcarbazepine on Background EEG Activity and Cognition in Epilepsy
por: Kim, Sung Min, et al.
Publicado: (2013)

Appraisal of the greenness profile of a chromatographic method for the simultaneous estimation of carbamazepine and oxcarbazepine, along with two potential impurities and three formulation excipients
por: Abdelwahab, Nada S., et al.
Publicado: (2021)

Associations of HLA genetic variants with carbamazepine‐induced cutaneous adverse drug reactions: An updated meta‐analysis
por: Biswas, Mohitosh, et al.
Publicado: (2022)

Direct costs of severe cutaneous adverse reactions in a tertiary hospital in Korea
por: Yang, Min-Suk, et al.
Publicado: (2019)

Population pharmacokinetic model development and its relationship with adverse events of oxcarbazepine in adult patients with epilepsy
por: Jang, Yoonhyuk, et al.
Publicado: (2021)

Posterior Reversible Encephalopathy Syndrome Related to Carbamazepine-Induced Hypertension
por: Kim, Ryul, et al.
Publicado: (2020)

Frequency and Pattern of Noninfectious Adverse Transfusion Reactions at a Tertiary Care Hospital in Korea
por: Cho, Jooyoung, et al.
Publicado: (2016)

Multi-Indication Carbamazepine and the Risk of Severe Cutaneous Adverse Drug Reactions in Korean Elderly Patients: A Korean Health Insurance Data-Based Study
por: Kim, Ji Young, et al.
Publicado: (2013)

Drug Hypersensitivity to Previously Tolerated Phenytoin by Carbamazepine-induced DRESS Syndrome
por: Kim, Cheol-Woo, et al.
Publicado: (2006)

Successful Treatment of a Paroxysmal Kinesigenic Dyskinesia Patient with Carbamazepine-Induced Stevens-Johnson Syndrome Using Oxcarbazepine Monotherapy: A Case Report
por: Tran, Hung T., et al.
Publicado: (2021)

Single OnabotulinumtoxinA Session Add-On to Carbamazepine or Oxcarbazepine in Treatment-Refractory Trigeminal Neuralgia: A Case Series with 24-Week Follow Up
por: Xiromerisiou, Georgia, et al.
Publicado: (2023)

Incidence of teicoplanin adverse drug reactions among patients with vancomycin-associated adverse drug reactions and its risk factors
por: Kim, Byung-Keun, et al.
Publicado: (2020)

Incidence and Economic Burden of Adverse Drug Reactions in Hospitalization: A Prospective Study in Korea
por: Seo, Bomi, et al.
Publicado: (2023)

Reintroduction of oxcarbazepine after allergic reaction in two pediatric patients with epilepsy
por: Yu, Lingyan, et al.
Publicado: (2021)

AS3MT Polymorphism: A Risk Factor for Epilepsy Susceptibility and Adverse Drug Reactions to Valproic Acid and Oxcarbazepine Treatment in Children From South China
por: Fan, Xiaomei, et al.
Publicado: (2021)

The adverse drug reactions to tumor necrosis factor alpha inhibitor
por: Park, Hye-Kyung, et al.
Publicado: (2014)

Carbamazepine-associated Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome
por: Sharma, Ankush, et al.
Publicado: (2021)

Adverse drug reaction monitoring in a tertiary care teaching hospital
por: Chawla, Shalini, et al.
Publicado: (2011)

Evaluation of hematologic profile may be needed for patients treated with oxcarbazepine
por: Jung, Gu Hyun, et al.
Publicado: (2019)

Uncontrolled headache induced by oxcarbazepine
por: Piovesan, Elcio Juliato, et al.
Publicado: (2007)

Real-World Efficiency of Pharmacogenetic Screening for Carbamazepine-Induced Severe Cutaneous Adverse Reactions
por: Chen, Zhibin, et al.
Publicado: (2014)

A comparative analysis of adverse drug reactions: pre- and post regional pharmacovigilance center in a single tertiary hospital
por: Nam, Young-Hee, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_52bo9vjj3nja1e81okel4ig1ff